cryptolepine has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Asdaq, SMB; Farhana, P; Mehraj, U; Mir, MA; Qayoom, H; Shafi, S | 1 |
| Bai, LP; Gao, J; Jiang, ZH; Li, T; Liu, Z; Tian, W; Xu, T; Zheng, Z; Zhu, GY | 1 |
| Ansah, C; Mensah, KB | 1 |
1 review(s) available for cryptolepine and Breast Neoplasms
| Article | Year |
|---|---|
A review of the anticancer potential of the antimalarial herbal cryptolepis sanguinolenta and its major alkaloid cryptolepine.
Topics: Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cryptolepis; Female; Humans; Indole Alkaloids; Inflammation; Male; NF-kappa B; Phytotherapy; Plant Preparations; Prostatic Neoplasms; Quinolines | 2013 |
2 other study(ies) available for cryptolepine and Breast Neoplasms
| Article | Year |
|---|---|
Cryptolepine Targets TOP2A and Inhibits Tumor Cell Proliferation in Breast Cancer Cells -
Topics: Antigens, Neoplasm; Breast Neoplasms; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Female; Humans; Indole Alkaloids; Neoplasm Recurrence, Local; Quinolines; Topoisomerase II Inhibitors | 2022 |
Cryptolepine suppresses breast adenocarcinoma via inhibition of HIF-1 mediated glycolysis.
Topics: Adenocarcinoma; Adenosine Triphosphate; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Female; Glycolysis; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Indole Alkaloids; Quinolines | 2022 |